REGENERON PHARMACEUTICALS, INC. (REGN)
Clinical trial NCT05246267 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2026-06-01 → 2027-08-01 3. primary completion date: 2026-06-01 → 2027-08-01 4. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (67%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical